A breakthrough in nanomedicine has made it possible to target and treat specific immune cells using nanoparticles. Researchers at the University of California, San Diego have developed a nanoparticle therapy that can selectively target and activate specific immune cells, with potential implications for the treatment of infectious diseases, cancer, and autoimmune disorders.

This new nanoparticle therapy works by targeting and activating antigen-presenting cells (APCs), which are a type of immune cell that plays a key role in initiating and orchestrating an immune response. By delivering therapeutic agents directly to APCs, this therapy can trigger a targeted immune response, allowing for greater control over the body’s immune system. The nanoparticles are engineered to bind to certain molecules on the surface of the APCs, triggering a signaling cascade that induces the APCs to activate. This process is known as antigen-specific immune activation, and it has been shown to be effective against a range of diseases.

Read Full Article Here

source: Phys.org